1. Home
  2. RCS vs SMTI Comparison

RCS vs SMTI Comparison

Compare RCS & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Strategic Income Fund Inc.

RCS

PIMCO Strategic Income Fund Inc.

HOLD

Current Price

$5.50

Market Cap

251.8M

Sector

Finance

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$21.85

Market Cap

208.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCS
SMTI
Founded
1994
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
251.8M
208.8M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
RCS
SMTI
Price
$5.50
$21.85
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$34.00
AVG Volume (30 Days)
143.5K
40.8K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
10.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
N/A
$12.48
P/E Ratio
N/A
$419.40
Revenue Growth
N/A
32.47
52 Week Low
$5.09
$16.05
52 Week High
$8.00
$35.70

Technical Indicators

Market Signals
Indicator
RCS
SMTI
Relative Strength Index (RSI) 52.43 53.38
Support Level $5.36 $18.20
Resistance Level $5.68 $24.17
Average True Range (ATR) 0.12 1.21
MACD 0.01 -0.22
Stochastic Oscillator 53.85 34.93

Price Performance

Historical Comparison
RCS
SMTI

About RCS PIMCO Strategic Income Fund Inc.

PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: